Advertisement

Introduction to Integrative Weight Management

  • Gerard E. MullinEmail author
  • Lawrence J. Cheskin
  • Laura E. Matarese
Chapter
Part of the Nutrition and Health book series (NH)

Abstract

Obesity has become a global pandemic with over one billion people world-wide are presently overweigh and/ or obese which surpasses malnutrition as the world’s most serious health problem. The number of Americans who are overweight and/or obese has doubled in adults and more than tripled in children and adolescents. Two-thirds of adults and one-third of children in the United States are overweight and obese. In June 2013, the American Medical Association (AMA) declared obesity a disease. Weight management is a branch of medicine that helps individuals achieve and maintain a healthy body weight. Integrative medicine embraces all evidence-based complementary and alternative medicine (CAM), conventional and traditional treatment modalities. Integrative Weight Management offer practitioners a weight management textbook that integrates the evidence about CAM-based therapies along with conventional and traditional weight management methods. This first chapter provides an overview of the entire book to assist the reader.

Keywords

Obesity Weight management Complementary alternative medicine Alternative medicine Dietary supplements Therapeutic diets Commercial weight-loss diets Surgery 

References

  1. 1.
    American Medical Association. American Medical Association classifying obesity as a disease may open up treatment options. 2013. http://www.cbsnews.com/8301-505263_162-57589997/american-medical-association-classifying-obesity-as-a-disease-may-open-up-treatment-options/. Accessed 30 June 2013.
  2. 2.
    Duncan AD, Liechty JM, Miller C, Chinoy G, Ricciardi R. Employee use and perceived benefit of a complementary and alternative medicine wellness clinic at a major military hospital: evaluation of a pilot program. J Altern Complement Med. 2011;17(9):809–15. PubMed PMID: 21834662.CrossRefPubMedGoogle Scholar
  3. 3.
    Davis MA, West AN, Weeks WB, Sirovich BE. Health behaviors and utilization among users of complementary and alternative medicine for treatment versus health promotion. Health Serv Res. 2011;46(5):1402–16. PubMed PMID: 21554272.CrossRefPubMedCentralPubMedGoogle Scholar
  4. 4.
    Hellmich N. Obamacare requires most insurers to tackle obesity. USA Today. 4 July 2013.Google Scholar
  5. 5.
    Initiative NOE. The practical guide: identification, evaluation, and treatment of overweight and obesity in adults. Bethesda: NIH; 2000.Google Scholar
  6. 6.
    Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity in the United States, 2009-2010. NCHS Data Brief. 2012;82:1–8. PubMed PMID: 22617494.PubMedGoogle Scholar
  7. 7.
    CDC. Adult obesity facts: obesity is common, serious and costly. 2013. http://www.cdc.gov/obesity/data/adult.html. Accessed 30 June 2013.
  8. 8.
    Ahrens W, Moreno LA, Pigeot I. Childhood obesity: prevalence worldwide. Epidemiology of obesity in children and adolescents. 1st ed. New York: Springer; 2011.Google Scholar
  9. 9.
    Zimmet P, Magliano D, Matsuzawa Y, Alberti G, Shaw J. The metabolic syndrome: a global public health problem and a new definition. J Atheroscler Thromb. 2005;12(6):295–300. PubMed PMID: 16394610.CrossRefPubMedGoogle Scholar
  10. 10.
    International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. Diabetes atlas2003. 2003. http://www.idforg/webdata/docs/IDF_Metasyndrome_definitionpdf
  11. 11.
    Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature. 1998;395(6704):763–70. PubMed PMID: 9796811.CrossRefPubMedGoogle Scholar
  12. 12.
    Tschop M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML. Circulating ghrelin levels are decreased in human obesity. Diabetes. 2001;50(4):707–9. PubMed PMID: 11289032.CrossRefPubMedGoogle Scholar
  13. 13.
    Batterham RL, Le Roux CW, Cohen MA, Park AJ, Ellis SM, Patterson M, et al. Pancreatic polypeptide reduces appetite and food intake in humans. J Clin Endocrinol Metab. 2003;88(8):3989–92. PubMed PMID: 12915697.CrossRefPubMedGoogle Scholar
  14. 14.
    Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature. 2006;444(7122):1022–3. PubMed PMID: 17183309. Epub 2006/12/22. eng.CrossRefPubMedGoogle Scholar
  15. 15.
    Turnbaugh PJ, Gordon JI. The core gut microbiome, energy balance and obesity. J Physiol. 2009;587(Pt 17):4153–8. PubMed PMID: 19491241. Pubmed Central PMCID: 2754355. Epub 2009/06/06. eng.CrossRefPubMedCentralPubMedGoogle Scholar
  16. 16.
    Cani PD, Knauf C, Iglesias MA, Drucker DJ, Delzenne NM, Burcelin R. Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor. Diabetes. 2006;55(5):1484–90. PubMed PMID: 16644709. Epub 2006/04/29. eng.CrossRefPubMedGoogle Scholar
  17. 17.
    Backhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A. 2004;101(44):15718–23. PubMed PMID: 15505215. Pubmed Central PMCID: 524219. Epub 2004/10/27. eng.CrossRefPubMedCentralPubMedGoogle Scholar
  18. 18.
    Machado MV, Cortez-Pinto H. Gut microbiota and nonalcoholic fatty liver disease. Ann Hepatol. 2012;11(4):440–9. PubMed PMID: 22700625. Epub 2012/06/16. eng.PubMedGoogle Scholar
  19. 19.
    Mozaffarian D, Hao T, Rimm EB, Willett WC, Hu FB. Changes in diet and lifestyle and long-term weight gain in women and men. N Engl J Med. 2011;364(25):2392–404. PubMed PMID: 21696306. Pubmed Central PMCID: 3151731. Epub 2011/06/24. eng.CrossRefPubMedCentralPubMedGoogle Scholar
  20. 20.
    Chung KH, Shin KO, Yoon JA, Choi KS. Study on the obesity and nutrition status of housewives in Seoul and Kyunggi area. Nutr Res Pract. 2011;5(2):140–9. PubMed PMID: 21556228. Pubmed Central PMCID: 3085803. Epub 2011/05/11. eng.CrossRefPubMedCentralPubMedGoogle Scholar
  21. 21.
    Woodard GA, Encarnacion B, Downey JR, Peraza J, Chong K, Hernandez-Boussard T, et al. Probiotics improve outcomes after Roux-en-Y gastric bypass surgery: a prospective randomized trial. J Gastrointest Surg. 2009;13(7):1198–204. PubMed PMID: 19381735. Epub 2009/04/22. eng.CrossRefPubMedGoogle Scholar
  22. 22.
    Luoto R, Kalliomaki M, Laitinen K, Isolauri E. The impact of perinatal probiotic intervention on the development of overweight and obesity: follow-up study from birth to 10 years. Int J Obes (Lond). 2010;34(10):1531–7. PubMed PMID: 20231842. Epub 2010/03/17. eng.CrossRefGoogle Scholar
  23. 23.
    Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011;34(3):274–85. PubMed PMID: 21623852.CrossRefPubMedGoogle Scholar
  24. 24.
    Shankar A, Xiao J. Positive relationship between plasma leptin level and hypertension. Hypertension. 2010;56(4):623–8. PubMed PMID: 20713919.CrossRefPubMedGoogle Scholar
  25. 25.
    Dorresteijn JA, Visseren FL, Spiering W. Mechanisms linking obesity to hypertension. Obes Rev. 2012;13(1):17–26. PubMed PMID: 21831233.CrossRefPubMedGoogle Scholar
  26. 26.
    McClave SA, Kushner R, Van Way 3rd CW, Cave M, DeLegge M, Dibaise J, et al. Nutrition therapy of the severely obese, critically ill patient: summation of conclusions and recommendations. J Parenter Enteral Nutr. 2011;35(5 Suppl):88S–96. PubMed PMID: 21881019.CrossRefGoogle Scholar
  27. 27.
    Fabricatore AN, Wadden TA. Psychological functioning of obese individuals. Diabetes Spectr. 2003;16(4):245–52.CrossRefGoogle Scholar
  28. 28.
    Agerstrom J, Rooth DO. The role of automatic obesity stereotypes in real hiring discrimination. J Appl Psychol. 2011;96(4):790–805.CrossRefPubMedGoogle Scholar
  29. 29.
    Karlsson J, Taft C, Ryden A, Sjöström L, Sullivan M. Ten-year trends in health-related quality of life after surgical and conventional treatment for severe obesity: the SOS intervention study. Int J Obes. 2007;31(8):1248–61. PubMed PMID: 17356530. Epub 2007/03/16. eng.CrossRefGoogle Scholar
  30. 30.
    Kolotkin RL, Davidson LE, Crosby RD, Hunt SC, Adams TD. Six-year changes in health-related quality of life in gastric bypass patients versus obese comparison groups. Surg Obes Relat Dis. 2012;8(5):625–33. PubMed PMID: 22386053. Epub 2012/03/06. Eng.CrossRefPubMedCentralPubMedGoogle Scholar
  31. 31.
    Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289(1):76–9. PubMed PMID: 12503980.CrossRefPubMedGoogle Scholar
  32. 32.
    Bailey RL, Gahche JJ, Lentino CV, Dwyer JT, Engel JS, Thomas PR, et al. Dietary supplement use in the United States, 2003-2006. J Nutr. 2011;141(2):261–6. PubMed PMID: 21178089. Pubmed Central PMCID: 3021445. Epub 2010/12/24. eng.CrossRefPubMedCentralPubMedGoogle Scholar
  33. 33.
    Poddar K, Kolge S, Bezman L, Mullin GE, Cheskin LJ. Nutraceutical supplements for weight loss: a systematic review. Nutr Clin Pract. 2011;26(5):539–52. PubMed PMID: 21947637.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Gerard E. Mullin
    • 1
    Email author
  • Lawrence J. Cheskin
    • 2
  • Laura E. Matarese
    • 3
  1. 1.Department of GastroenterologyJohns Hopkins HospitalBaltimoreUSA
  2. 2.Weight Management CenterJohns Hopkins HospitalBaltimoreUSA
  3. 3.Division of Gastroenterology and Hepatology, Brody School of MedicineEast Carolina UniversityGreenvilleUSA

Personalised recommendations